SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001005477-08-002267
Filing Date
2008-03-17
Accepted
2008-03-17 19:43:30
Documents
1
Period of Report
2008-03-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 edgar123.html 3  
1 FORM 3 edgar123.xml 3 2471
  Complete submission text file 0001005477-08-002267.txt   4185
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Issuer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address
SCHALLER CHARLES R (Reporting) CIK: 0000903696 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-15006 | Film No.: 08694596